Navigation Links
Kaiser Permanente Recognized by NCQA for Innovative Program to Reduce Health Care Disparities
Date:11/16/2007

s in the community. More than 10,000 reference manuals have been shipped since 2006.

Moving forward, Kaiser Permanente is incorporating the standardized quality translation process into a web-based environment, thereby facilitating shared access, creating opportunities for collaboration, reducing translation redundancy, and improving translation quality through systematic application of the evidence-based quality assurance and quality improvement process.

"It is a major priority for Kaiser Permanente to be culturally competent in every aspect of our care delivery and service," said George C. Halvorson, chairman and CEO of Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals. "We are honored to be acknowledged by the NCQA for our accomplishments in further breaking the barriers to health communication by providing accurate and usable health information to our members and the communities we serve."

According to the landmark 2002 Institute of Medicine study, "Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care," minorities in the U.S. tend to get lower quality health care than whites, even when such factors as medical conditions, insurance and economic status are equivalent.

Kaiser Permanente received its award in Washington, D.C. on November 13 during the second annual "Breakthroughs in Reducing Health Care Disparities." The award was initiated after the NCQA -- with major funding from The California Endowment and support from the Centers for Medicare & Medicaid Services -- started to investigate the feasibility for health plans to provide culturally and linguistically appropriate care and to monitor health care disparities using clinical quality data.

For information about the other health plans recognized in 2007 by NCQA, as well the conferences on multicultural health care, visit http://www.ncqa.org.

About Kaiser Permanente

Kaiser Perman
'/>"/>

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Webcast Alert: Kaiser Permanente Residency Program Open House
2. Kaiser Permanente Achieves Climate Action Leader Status
3. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
4. Kaiser Permanente Study Shows Alcohol Consumption - No Matter Beverage Type - Linked to Breast Cancer Risk
5. Kaiser Permanente Study Shows One in Seven Women are Depressed Before, During, or After Pregnancy
6. Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council
7. WellBound Teams With Kaiser Permanente to Open New Self-Care Dialysis Center in Sacramento, CA
8. Kaiser Permanente Joins With Top Health Care Groups to Create Healthier Hospital Environments
9. Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care
10. Kaiser Permanente CEO Receives Diversity Leadership Award
11. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 1Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 2Beckman Coulter Announces the Creation of Beckman Coulter Genomics 54297 1Beckman Coulter Announces the Creation of Beckman Coulter Genomics 54297 2Beckman Coulter Announces the Creation of Beckman Coulter Genomics 54297 3Biostar Pharmaceuticals Inc to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday August 14 2009 at 10 3A30 a m EDT 13519 1Biostar Pharmaceuticals Inc to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday August 14 2009 at 10 3A30 a m EDT 13519 2Biostar Pharmaceuticals Inc to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday August 14 2009 at 10 3A30 a m EDT 13519 3